Ticker Details
Lifecore Biomedical, Inc.
IPO Date:	March 1, 1996
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$178.17M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.20 | 3.25%
Avg Daily Range (30 D):	$0.17 | 3.24%
Avg Daily Range (90 D):	$0.17 | 3.22%

Institutional Daily Volume
Avg Daily Volume:	.04M
Avg Daily Volume (30 D):	.18M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	86

Institutional Trades
Total Institutional Trades:	35
Avg Institutional Trade:	$2.63M
Avg Institutional Trade (30 D):	$1.8M
Avg Institutional Trade (90 D):	$1.37M
Avg Institutional Trade Volume:	.38M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.23M
Avg Closing Trade (30 D):	$2.3M
Avg Closing Trade (90 D):	$1.52M
Avg Closing Volume:	592.77K

News

Apr 6, 2026 @ 12:00 PM Pomerantz LLP and The Rosen Law Firm, P.A. Announc... Source: Na

Mar 23, 2026 @ 11:00 AM Lifecore Biomedical Signs Commercial Site Transfer... Source: Na

Mar 17, 2026 @ 12:02 AM Green Dot Corporation Shareholders Are Encouraged ... Source: Johnson Fistel, Pllp

Mar 16, 2026 @ 9:56 PM Lifecore Biomedical Shareholders Are Encouraged to... Source: Johnson Fistel, Pllp

Jan 16, 2026 @ 9:45 PM Lifecore Announces Inducement Grants Under Nasdaq ... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.43	$-.03	$-1.27
Diluted EPS	$-.43	$-.03	$-1.27
Revenue	$23.19M	$36.44M	$128.87M
Gross Profit	$4.46M	$13.98M	$40.3M
Net Income / Loss	$-14.98M	$-1.15M	$-38.72M
Operating Income / Loss	$-4.67M	$5.33M	$-17.25M
Cost of Revenue	$18.73M	$22.46M	$88.57M
Net Cash Flow	$3.33M	$2.85M	$-.2M
PE Ratio